Patient P-02346

Synthetic patientMETA-24 · Day 177 · 25–34 · M · baseline S04Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Improving

GI state

Favorable

Inflammatory state

Improving

Nutritional resilience

Improving

Discontinuation risk

16%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S04
Day 14 Trajectory diverged from prediction — Observed response fell below the model's expected path.

What changed?

Trajectory began diverging from predicted response on Day 14.

Primary contributors, last 14 days

Toxicity-21
Inflammatory activity-13
Nutritional resilience+9

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

65 min

worsening · -4.3 vs previous 14 d

Sleep duration

Wearable

6 h

worsening · -0.3 vs previous 14 d

Energy level

Daily log

6.3/10

worsening · -0.7 vs previous 14 d

Steps

Wearable

7,299

worsening · -738 vs previous 14 d

GI burden

Companion

23.1/100

worsening · +15.2 vs previous 14 d

Adherence

Companion

92.4 %

stable · -2.5 vs previous 14 d

Sleep quality

Wearable

35.3/100

worsening · -9.2 vs previous 14 d

Glucose, CGM daily mean

CGM

134 mg/dL

worsening · +7.1 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 71 from the failing basin, 23 from restoration.

Good elements to keep

Protein (supports)
perturbation · steering +8.7
Butyrate producers intact
hidden · steering +7.5
Daily walks resumed
perturbation · steering +3.3
Protein
supporter · GI -4.6 next day

Main detractors to watch

Rapid metabolizer
hidden · steering -8
Bacteroides fragilis elevated
hidden · steering -7.4
Antibiotic course
perturbation · steering -4.7
Poor-sleep week
perturbation · steering -3

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-4.6supporter · 95%
Simple carbohydrates
-1.8no signal · 42%
Ultra-processed food
+1.1no signal · 31%
Caffeine
+0.9no signal · 18%
Alcohol
-0.6no signal · 15%
Insoluble fibre
+0.3no signal · 15%
Histamine load
-0.2no signal · 15%
Dietary fat load
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
Autonomic recovery ↑20
- WearableShort sleep window
Mucosal barrier integrity ↓10
- WearableSleep 6.0 h, below personal baseline

DNA

Fictional pharmacogenomic panel

CYP2D6 Rapid metabolizer
Expected exposure

Microbiome

Shannon diversity 3.5 · butyrate capacity 45/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 46 ms
Sleep: 6.1 h
Steps: 6,294
Resting HR: 60 bpm

Daily log: GI score 23, nutritional resilience 66, adherence 92.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02031	37%	S12	AD-05	improved	47
P-02285	35%	S14	AD-05	no change	39
P-02093	32%	S05	AD-05	no change	40
P-02483	42%	S06	BR-03	no change	64
P-02267	36%	S09	BR-03	no change	45
P-02280	36%	S07	BR-03	no change	50
P-02087	35%	S01	BR-03	no change	40
P-02522	35%	S01	BR-03	no change	40
P-02354	35%	S01	CR-01	improved	78
P-02462	46%	S12	DT-01	improved	65
P-02491	46%	S09	DT-01	no change	65
P-02235	43%	S14	DT-01	improved	50